Skip to content
Screener

PP&E (Net) at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$157M+51.0%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$13.38M+1,792%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$136.28M-17.1%
Bioventus logo
BioventusBVS
$20.53M-16.3%
Organon logo
OrganonOGN
$1.28B+6.9%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$12.54K-21.1%

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$955.82M-16.0%
Enterprise value$810.41M-19.5%
P/E20×-11.4×
P/S1.2×-0.4×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851
Line itemJune 30,2026December 31,2025
Prepaid expenses and other current assets60,32632,642
Restricted cash19,85019,850
Total current assets608,014691,411
Property and equipment, net10,65312,013
Operating lease assets3,7914,187
Intangible assets, net1,186,084669,510
Restricted cash1,0601,056
Deferred tax assets120,774112,539

Item 1. Condensed Consolidated Financial Statements (Unaudited).

FAQ

What is Collegium Pharmaceutical, Inc.'s PP&E (net)?
Collegium Pharmaceutical, Inc. (COLL) reported PP&E (net) of $10.65M in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s PP&E (net) changed year-over-year?
Collegium Pharmaceutical, Inc.'s PP&E (net) decreased by 17.4% year-over-year, from $12.9M to $10.65M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s PP&E (net) has grown at a -8.7% compound annual growth rate (CAGR), from $18.99M to $12.01M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Collegium Pharmaceutical, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude